Merck & Co. Inc. (MRK) Stock 2026 Review

Merck & Co. (NYSE: MRK) shows strong performance with a solid dividend yield and impressive returns over the past year and five years. Analysts maintain a favorable outlook, suggesting it could be a resilient investment.

The current dividend yield for Merck & Co. Inc. is 2.88%. This yield highlights the company's commitment to returning value to its shareholders.

Merck has achieved a return of 35.08% over the past year, indicating strong performance and potential for growth. This is a positive signal for investors considering the stock.

Over the last five years, Merck has delivered a return of 52.35%. This long-term performance reflects the company's strength and resilience in the market.

Jim Cramer believes Merck & Co. is likely to outperform in a market facing higher energy costs and economic uncertainty. His positive outlook adds to the confidence in the stock.

Merck expects its 2026 revenue to be between $65.5 billion and $67.0 billion. This forecast is slightly below the average analyst estimate, indicating cautious optimism.

Merck outperformed Pfizer in net income, generating a profit compared to Pfizer's net loss. Additionally, Merck led in operating cash flow, suggesting it may be a stronger investment choice.